Silver Cross Hospital

The way you should be treated.™

My SilverCross


New Treatment to Prevent Esophageal Cancer Caused by GERD/Heartburn Available at Silver Cross Hospital

Local Gastroenterologist Hosts Free Program March 31

Joliet, IL (March 17, 2010)--An outpatient treatment that destroys pre-cancerous tissue in the lining of the esophagus is now available at Silver Cross Hospital.

The procedure, endoscopic radiofrequency ablation therapy using the HALO System, is a highly effective treatment for complete eradication of Barrett’s esophagus, a pre-cancerous condition that affects one to two million adults in the U.S. each year.


woman-eatingAccording to Kamran Ayub, M.D., a gastroenterologist on the medical staff at Silver Cross who is specially trained in the ablation therapy and performed the first procedures at Silver Cross, Barrett’s esophagus occurs when the esophagus is chronically exposed to contents of the stomach caused by gastroesophageal reflux disease, commonly known as GERD or heartburn.  With prolonged acid exposure, normal cells in the esophagus can undergo a genetic change and are then vulnerable to further changes that can lead to cancer.

Individuals with Barrett’s esophagus have a 40 to 130 times higher incidence of developing esophageal cancer than those without the condition. Esophageal cancer is presently the fastest growing form of malignancy in the United States.

“The main purpose of the ablation procedure is to remove the abnormal lining of the esophageal,” says Dr. Ayub. “The tissue then regenerates and normal tissue grows back. This reduces and even eliminates the chances of cancer developing. Data from studies shows that the treatment is highly effective.”

During the procedure, an ablation catheter is positioned on the abnormal esophageal tissue. Using the HALO Energy Generator, the physician delivers a rapid burst of ablative energy which removes a very thin layer of the esophagus. The procedure is performed in an outpatient setting, without incisions, and takes less than 30 minutes on average.

For a person with Barrett’s esophagus, Dr. Ayub says the risk of developing esophageal cancer is similar to the risk of developing colon cancer for patients who have a colon polyp. However, unlike a colon polyp which is removed immediately upon diagnosis through a colonoscopy, prior to the availability of the HALO System, the standard treatment for Barrett’s disease was “watchful waiting” or surveillance to monitor the progression of the disease.

“Previously we could use ablation therapy to remove or destroy pre-cancerous tissue, but the technology had limitations and wasn’t widely used,” says Dr Ayub. “The HALO System provides uniform and controlled ablative therapy, which removes the abnormal cells and allows for regrowth of normal cells. It’s also easier to effectively treat patients using the HALO System, without injuring healthy underlying tissue.”

According to Dr. Ayub, esophageal cancer is often uncurable because the disease is frequently discovered in the advanced stages. Esophageal cancer has a five-year patient survival rate of just 16%.

“It usually starts with GERD, which can cause Barrett’ esophagus, which can lead to esophageal cancer,” says Dr. Ayub. “That’s why it’s important to seek medical treatment for symptoms of GERD, the most common being heartburn.”

For a referral to a physician at Silver Cross who performs endoscopic radiofrequency ablation therapy, call 1-888-660-HEAL (4325). 


  • Silver Cross Hosts Free Stroke Symposium for Physicians, Nurses & Paramedics

  • Robert Crown Students Learn about Advanced Stroke Care at Silver Cross

  • Silver Cross Encore Shop Plans Back to School Sale Aug. 5 & 6


Social Media

Thomson Reuters Top 100 Hospitals

Located at 1900 Silver Cross Blvd., New Lenox, IL 60451   Main Phone (815) 300-1100

© Copyright 2013 Silver Cross Hospital. All Rights Reserved.